Home » Videos » News18 Shorts » Covaxin, India’s First COVID-19 Vaccine, Cleared For Phase 3 Human Trial

Covaxin, India’s First COVID-19 Vaccine, Cleared For Phase 3 Human Trial

Oct 23, 2020 03:20 PM IST iVideos iVideos
Share

Covaxin, India’s first COVID-19 vaccine, has been cleared for Phase 3 Human Trial. This has come as a big boost to India’s efforts to develop an indigenous COVID-19 vaccine. Covaxin is Bharat Biotech’s COVID-19 vaccine candidate Phase 3 trial of Covaxin may start from the first week of November.

Read all the Latest News and Breaking News here